Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of malignant hyperthermia susceptibility.
Guis
S
S
Centre de Résonance Magnétique Biologique et Médicale, Faculté de Médicine, Marseille, France. patrick.cozzone@medecine.univ-mrs.fr
Bendahan
D
D
Kozak-Ribbens
G
G
Figarella-Branger
D
D
Mattei
J P
JP
Pellissier
J F
JF
Treffouret
S
S
Bernard
V
V
Lando
A
A
Cozzone
P J
PJ
D000069059:Atorvastatin; D002800:Cholinesterase Inhibitors / Q000009:adverse effects*; D004198:Disease Susceptibility; D005260:Female; D006538:Heptanoic Acids / Q000009:adverse effects*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D008305:Malignant Hyperthermia / Q000175:diagnosis*; D008875:Middle Aged; D010146:Pain / Q000139:chemically induced*; D011758:Pyrroles / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced*
D002800:Cholinesterase Inhibitors; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin